Skip to main content
Equibles

PRICE T ROWE ASSOCIATES INC /MD/

Position in EDIT — Editas Medicine, Inc.

CIK 80255 BALTIMORE, MD
Back to EDIT Full portfolio

Position in EDIT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$386,949
+$119,041 QoQ
Shares Held
119,429
+10.1% QoQ
Ownership
0.078%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#64
of 216 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EDIT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. EDIT ranks #218 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 2,678,047 $2,484,611,664
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,529,709 $953,834,749
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,728,421 $858,558,562
4 KYMR
Kymera Therapeutics, Inc.
 7,112,980 $815,645,416
5 RPRX
Royalty Pharma plc
 11,193,657 $627,628,347
6 RVMD
Revolution Medicines, Inc.
 2,969,853 $447,655,945
7 MRNA
Moderna, Inc.
 5,589,560 $391,436,886
8 TWST
Twist Bioscience Corp
 3,634,652 $373,932,997

All Filings in EDIT

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $386,949 119,429
2026-03-31 $267,908 108,465
2025-12-31 $189,413 92,397
2025-09-30 $299,183 86,220
2025-06-30 $116,901 53,137
2025-03-31 $50,781 43,777
2024-12-31 $55,596 43,777
2024-09-30 $221,029 64,818
2024-06-30 $244,964 52,455
2024-03-31 $368,803 49,704
2023-12-31 $430,828 42,530
2023-09-30 $341,577 43,792
2023-06-30 $293,753 35,693
2023-03-31 $254,525 35,107
2022-12-31 $268,113 30,227
2022-09-30 $423,601 34,608
2022-06-30 $363,890 30,760
2022-03-31 $475,538 25,002
2021-12-31 $625,863 23,573
2021-09-30 $1,765,125 42,968
2021-06-30 $2,188,796 38,644
2021-03-31 $1,342,362 31,961
2020-12-31 $1,888,623 26,938
2020-09-30 $414,530 14,773